Düsseldorf/Amsterdam, 20 September 2022 – As of September 2022 Holland Capital is a full member of The German Private Equity and Venture Capital Association (BVK). With this membership, Holland Capital confirms its commitment to the German private equity market.
BVK: face and voice of the private equity industry
BVK is the face and voice of the private equity industry in Germany, they campaign for improvements to the fiscal environment and for easier access to private equity so that even more companies in Germany can benefit from private equity. BVK takes a stand on policy issues and the media in an effort to underline how important private equity is for the German economy. They observe the market and analyse its trends, as private equity can be a growth engine for innovation, start-ups and SME’s. www.bvkap.de
Holland Capital is committed to the German market
Ewout Prins, managing partner Holland Capital, “Holland Capital has been active for over 40 years as a private equity investor within the Healthcare and Technology sectors in the Dutch market. We see interesting opportunities in the German market for our investment strategy. To support the expansion of our activities into the German market, we opened our Düsseldorf office last year. We look forward to working with German entrepreneurs, investors and advisers. As such, we are pleased to have become member of the BVK. We shall be happy to contribute to the German Private Equity industry”.
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful entrepreneurs in the relevant growth markets and has her offices in Amsterdam (NL) and Düsseldorf (D).
Holland Capital invests in nanotech company Kriya Materials
Amsterdam August 5, 2022 – Holland Capital is investing in Kriya Materials (Kriya), a leading developer of advanced nanotechnology-based custom coating solutions. The funding will be used to accelerate international expansion. Advanced coating solutions Kriya...
Holland Capital invests in Health IT company Open HealthHub
Amsterdam, 26 July 2022 – Holland Capital is investing in Open HealthHub, a digital platform that allows healthcare providers and patients to exchange medical data safely and securely. It will also reduce the administrative burden on healthcare providers. The...
Mauritskliniek intends to join Corius
Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The...
Holland Capital realizes successful exit of Humeca to i4hi
Holland Capital realizes successful exit of Humeca to i4hi Borne / Amsterdam, 5 July 2022 – Investment company Holland Capital realizes a successful exit of Humeca to fellow investor i4hi. Humeca is a leading supplier of innovative products in the field of advanced...
AMP Group acquires Omega Logistics business operations
AMP Group acquires Omega Logistics business operations Houten, 23 May 2022 - Our portfolio company AMP is taking its second step in the buy-and-build strategy with the acquisition of the business activities of Omega Logistics, a medical logistics provider. Through...
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems Amsterdam, 21 March 2022 – We’re proud to announce that our portfolio company, CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis, has been acquired by...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01


